China Stroke Registry for Patients With Traditional Chinese Medicine

China Stroke Registry for Patients With Traditional Chinese Medicine (CASES-TCM): A Prospective, Multicenter, Observational Study

The CASES-TCM study is a prospective, multicenter, observational study, which will enroll 20,000 patients with acute stroke (ischemic stroke or intracerebral hemorrhage) within 7 days of symptom onset.

This study attempts to depict major clinical characteristics of acute stroke in patients with Chinese medicine treatment and to explore any difference compared with other non-Chinese medicine use cohorts and the effectiveness and safety of Chinese medicine.

Inclusion Criteria:

• ≥18 years of age
• Diagnosed as acute ischemic stroke or intracerebral hemorrhage
• Within 7 days of symptom onset

Exclusion Criteria:

• Refusal to give informed consent
• Have difficulties completing follow-up